OOIR: Observatory of International Research

Papers

(The H4-Index of Atherosclerosis is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	204
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	159
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	157
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	139
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	113
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	105
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	100
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	98
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	97
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	94
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	85
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	80
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	76
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	71
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	70
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	68
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	63
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	62
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	57
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	56
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	55
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	54
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	53
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	53
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	53

ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	51
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	51
Rabies vaccine induced microangiopathy	50
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	49
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	49
IL-21R blockade reduces atherosclerosis development	46
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	45
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	43
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	42
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	42
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	42
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	40
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	40
TREM2 macrophages in adipose tissue and cardiovascular risk	39
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	39
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	39